Food Effect in Healthy Participants
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CrestoneCRS3123 200 mg capsule
ORIC PharmaceuticalsORIC-114
EisaiE7386
Clinical Trials (3)
Total enrollment: 66 patients across 3 trials
Evaluation of the Potential Impact of a High-fat Meal on the Pharmacokinetics of CRS3123 in Healthy Adult Participants
Start: Apr 2025Est. completion: Jun 202517 patients
Phase 1Completed
Effect of Food on the Pharmacokinetics of ORIC-114
Start: Sep 2023Est. completion: Nov 202332 patients
Phase 1Completed
A Food-Effect Study of E7386 in Healthy Participants
Start: Jun 2019Est. completion: Oct 201917 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.